New roles of carboxypeptidase E in endocrine and neural function and cancer

Endocrine Reviews

Volumn 33, Issue 2, 2012, Pages 216-253

  Cawley, Niamh X ^a   Wetsel, William C ^b   Murthy, Saravana R K ^a   Park, Joshua J ^c   Pacak, Karel ^a   Loh, Y Peng ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOXYPEPTIDASE H; NEUROPEPTIDE;

ALTERNATIVE RNA SPLICING; AMNESIA; BEHAVIOR; BONE METABOLISM; CARCINOGENESIS; DENDRITE; DIABETES MELLITUS; EMOTION; ENDOCRINE FUNCTION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME STRUCTURE; GENE MUTATION; HORMONE TRANSPORT; HUMAN; INFERTILITY; LEARNING DISORDER; METASTASIS; MOOD; NEOPLASM; NERVOUS SYSTEM FUNCTION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SECRETORY VESICLE; SEXUAL BEHAVIOR; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; SYNAPSE VESICLE; TUMOR GROWTH;

ANIMALS; CARBOXYPEPTIDASE H; CENTRAL NERVOUS SYSTEM; ENDOCRINE SYSTEM; HUMANS; MODELS, ANIMAL; NEOPLASMS;

EID: 84862612680     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2011-1039     Document Type: Review

References (359)

1. Steiner DF, 1998 The proprotein convertases. Curr Opin Chem Biol 2:31-39
2. Fricker LD, Snyder SH. 1982 Enkephalin convertase: purification and characterization of a specific enkephalinsynthesizing carboxypeptidase localized to adrenal chromaffin granules. Proc Natl Acad Sci USA 79:3886-3890
3. Hook VY, Eiden LE, Brownstein MJ. 1982 A carboxypeptidase processing enzyme for enkephalin precursors. Nature 295:341-342
4. Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SRK. 2011 The extended granin family: structure, function and biomedical implications. Endocr Rev 32:755-797
5. Lewis MJ, Pelham HR. 1990 A human homologue of the yeast HDEL receptor. Nature 348:162-163
6. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH. 1995 Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 10:135-142
7. Cawley NX, Zhou J, Hill JM, Abebe D, Romboz S, Yanik T, Rodriguiz RM, Wetsel WC, Loh YP. 2004 The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. Endocrinology 145:5807-5819
8. Lee TK, Murthy SR, Cawley NX, Dhanvantari S, Hewitt SM, Lou H, Lau T, Ma S, Huynh T, Wesley RA, Ng IO, Pacak K, Poon RT, Loh YP. 2011 An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers. J Clin Invest 121:880-892
9. Reznik SE, Fricker LD. 2001 Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding. Cell Mol Life Sci 58:1790-1804
10. Rawlings ND, Barrett AJ, 1995 Evolutionary families of metallopeptidases. Methods Enzymol 248:183-228
11. Osterman AL, GrishinNV,Smulevitch SV,MatzMV,Zagnitko OP, Revina LP, Stepanov VM. 1992 Primary structure of carboxypeptidase T: delineation of functionally relevant features in Zn-carboxypeptidase family. J Protein Chem 11:561-570
12. Fricker LD, Evans CJ, Esch FS, Herbert E. 1986 Cloning and sequence analysis of cDNA for bovine carboxypeptidase E. Nature 323:461-464
13. Rodríguez C, Brayton KA, Brownstein M, Dixon JE. 1989 Rat preprocarboxypeptidase H. Cloning, characterization, and sequence of the cDNA and regulation of themRNAby corticotropin-releasing factor. J Biol Chem 264:5988- 5995
14. Jung YK, Kunczt CJ, Pearson RK, Dixon JE, Fricker LD. 1991 Structural characterization of the rat carboxypeptidase-E gene. Mol Endocrinol 5:1257-1268
15. Billova S, Galanopoulou AS, Seidah NG, Qiu X, Kumar U. 2007 Immunohistochemical expression and colocalization of somatostatin, carboxypeptidase-E and prohormone convertases 1 and 2 in rat brain. Neuroscience 147:403- 418
16. Manser E, Fernandez D, Loo L, Goh PY, Monfries C, Hall C, Lim L. 1990 Human carboxypeptidase E. Isolation and characterization of the cDNA, sequence conservation, expression and processing in vitro. Biochem J 267:517-525
17. Zhang X, Zhu J, Loh YP, Berghman LR. 2009 Carboxypeptidase E, an essential element of the regulated secretory pathway, is expressed and partially co-localized with chromogranin A in chicken thymus. Cell Tissue Res 337:371- 379
18. Jacob TC, Kaplan JM. 2003 The EGL-21 carboxypeptidase Efacilitates acetylcholine release at Caenorhabditis elegans neuromuscular junctions. J Neurosci 23:2122-2130
19. Sakate R, Suto Y, Imanishi T, Tanoue T, Hida M, Hayasaka I, Kusuda J, Gojobori T, Hashimoto K, Hirai M. 2007 Mapping of chimpanzee full-length cDNAs onto the human genome unveils large potential divergence of the transcriptome. Gene 399:1-10
20. Osada N, Hirata M, Tanuma R, Kusuda J, Hida M, Suzuki Y, Sugano S, Gojobori T, Shen CK, Wu CI, Hashimoto K. 2005 Substitution rate and structural divergence of 5'UTR evolution: comparative analysis between human and cynomolgus monkey cDNAs. Mol Biol Evol 22:1976-1982
21. Cargill EJ, Baskin LC, Pomp D. 1998 Rapid communication: localization of the porcine carboxypeptidase-E gene by linkage analysis further extends the region of synteny between human chromosome 4 and porcine chromosome J Anim Sci 76:2211-2212
22. Klein SL, Strausberg RL, Wagner L, Pontius J, Clifton SW, Richardson P. 2002 Genetic and genomic tools for Xenopus research: the NIH Xenopus initiative. Dev Dyn 225:384- 391
23. Fan X, Nagle GT. 1996 Molecular cloning of Aplysia neuronal cDNAs that encode carboxypeptidases related to mammalian prohormone processing enzymes. DNA Cell Biol 15:937-945
24. Vihtelic TS, Fadool JM, Gao J, Thornton KA, Hyde DR, Wistow G. 2005 Expressed sequence tag analysis of zebrafish eye tissues for NEIBank. Mol Vis 11:1083-1100
25. Heinrich B, Zhang Z, Raitskin O, Hiller M, Benderska N, Hartmann AM, Bracco L, Elliott D, Ben-Ari S, Soreq H, Sperling J, Sperling R, Stamm S. 2009 Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA. J Biol Chem 284:14303-14315
26. Pickrell JK, Pai AA, Gilad Y, Pritchard JK. 2010 Noisy splicing drives mRNA isoform diversity in human cells. PLoS Genet 6:e1001236
27. Tsai KW, Chan WC, Hsu CN, Lin WC. 2010 Sequence features involved in the mechanism of 3' splice junction wobbling. BMC Mol Biol 11:34
28. Zhang J, Kuo CC, Chen L. 2011 GC content around splice sites affects splicing through pre-mRNA secondary structures. BMC Genomics 12:90
29. Karambataki M, Malousi A, Maglaveras N, Kouidou S. 2010 Synonymous polymorphisms at splicing regulatory sites are associated with CpGs in neurodegenerative disease-related genes. Neuromolecular Med 12:260-269
30. Palaniswamy R, Teglund S, Lauth M, Zaphiropoulos PG, Shimokawa T. 2010 Genetic variations regulate alternative splicing in the 5' untranslated regions of the mouse gliomaassociated oncogene 1, Gli1. BMC Mol Biol 11:32
31. Kumari S, Bugaut A, Huppert JL, Balasubramanian S. 2007 An RNA G-quadruplex in the 5' UTR of the NRAS protooncogene modulates translation. Nat Chem Biol 3:218- 221
32. Kozak M. 1991 Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 266:19867-19870
33. Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, Wang H, Williams A, Blume JE. 2007 Discovery of tissuespecific exons using comprehensive human exon microarrays. Genome Biol 8:R64
34. Castle JC, Zhang C, Shah JK, Kulkarni AV, Kalsotra A, Cooper TA, Johnson JM. 2008 Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat Genet 40:1416-1425
35. Ishikawa T, Murakami K, Kido Y, Ohnishi S, Yazaki Y, Harada F, Kuroki K. 1998 Cloning, functional expression, and chromosomal localization of the human and mouse gp180-carboxypeptidase D-like enzyme. Gene 215:361- 370
36. Song L, Fricker L 1995 Processing of procarboxypeptidase E into carboxypeptidase E occurs in secretory vesicles. J Neurochem 65:444-453
37. Parkinson D. 1990 Two soluble forms of bovine carboxypeptidaseHhave different NH2-terminal sequences. J Biol Chem 265:17101-17105
38. Song L, Fricker LD 1997 The pro region is not required for the expression or intracellular routeing of carboxypeptidase E. Biochem J 323:265-271
39. Song L, Fricker LD. 1995 Calcium- and pH-dependent aggregation of carboxypeptidase E. J Biol Chem 270:7963- 7967
40. Rindler MJ 1998 Carboxypeptidase E, a peripheral membrane protein implicated in the targeting of hormones to secretory granules, co-aggregates with granule content proteins at acidic pH. J Biol Chem 273:31180-31185
41. Cool DR, Normant E, Shen F, Chen HC, Pannell L, Zhang Y, Loh YP, 1997 Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe(fat) mice. Cell 88:73-83
42. Cool DR, Loh YP. 1998 Carboxypeptidase E is a sorting receptor for prohormones: binding and kinetic studies. Mol Cell Endocrinol 139:7-13
43. Zhang CF, Snell CR, Loh YP. 1999 Identification of a novel prohormone sorting signal-binding site on carboxypeptidase E, a regulated secretory pathway-sorting receptor. Mol Endocrinol 13:527-536
44. Fricker LD. 1988 Activation and membrane binding of carboxypeptidase E. J Cell Biochem 38:279-289
45. Fricker LD, Das B, Angeletti RH. 1990 Identification of the pH-dependent membrane anchor of carboxypeptidase E (EC 3.4.17.10). J Biol Chem 265:2476-2482
46. Mitra A, Song L, Fricker LD, 1994 The C-terminal region of carboxypeptidase E is involved in membrane binding and intracellular routing in AtT-20 cells. J Biol Chem 269: 19876-19881
47. Zhang CF, Dhanvantari S, Lou H, Loh YP. 2003 Sorting of carboxypeptidase E to the regulated secretory pathway requires interaction of its transmembrane domain with lipid rafts. Biochem J 369:453-460
48. Dhanvantari S, Loh YP. 2000 Lipid raft association of carboxypeptidase E is necessary for its function as a regulated secretory pathway sorting receptor. J Biol Chem 275: 29887-29893
49. Dhanvantari S, Arnaoutova I, Snell CR, Steinbach PJ, Hammond K, Caputo GA, London E, Loh YP. 2002 Carboxypeptidase E, a prohormone sorting receptor, is anchored to secretory granules via a C-terminal transmembrane insertion. Biochemistry 41:52-60
50. Klemm RW, Ejsing CS, Surma MA, Kaiser HJ, Gerl MJ, Sampaio JL, de Robillard Q, Ferguson C, Proszynski TJ, Shevchenko A, Simons K. 2009 Segregation of sphingolipids and sterols during formation of secretory vesicles at the trans-Golgi network. J Cell Biol 185:601-612
51. Fricker LD, Devi L. 1993 Posttranslational processing of carboxypeptidase E, a neuropeptide-processing enzyme, in AtT-20 cells and bovine pituitary secretory granules. J Neurochem 61:1404-1415
52. Hook VY. 1985 Differential distribution of carboxypeptidase-processing enzyme activity and immunoreactivity in membrane and soluble components of chromaffin granules. J Neurochem 45:987-989
53. Arnaoutova I, Jackson CL, Al-Awar OS, Donaldson JG, Loh YP. 2003 Recycling of raft-associated prohormone sorting receptor carboxypeptidase E requires interaction with ARF6. Mol Biol Cell 14:4448-4457
54. Wu CM, Chang HT, Chang MD. 2004 Membrane-bound carboxypeptidase E facilitates the entry of eosinophil cationic protein into neuroendocrine cells. Biochem J 382: 841-848
55. Ren J, Kachel K, Kim H, Malenbaum SE, Collier RJ, London E. 1999 Interaction of diphtheria toxin T domain with molten globule-like proteins and its implications for translocation. Science 284:955-957
56. Brambillasca S, Yabal M, Soffientini P, Stefanovic S, Makarow M, Hegde RS, Borgese N. 2005 Transmembrane topogenesis of a tail-anchored protein is modulated by membrane lipid composition. EMBO J 24:2533-2542
57. Brambillasca S, Yabal M, Makarow M, Borgese N. 2006 Unassisted translocation of large polypeptide domains across phospholipid bilayers. J Cell Biol 175:767-777
58. Luuk H, Toots U, Koks S, Vasar E. 2005 N-terminal domain of Wolframin interacts with carboxypeptidase E. Eur Neuropsychopharmacol 15:S5-S6
59. Koks S, Luuk H, Nelovkov A, Areda T, Vasar E. 2004 A screen for genes induced in the amygdaloid area during cat odor exposure. Genes Brain Behav 3:80-89
60. Saito N, Takeuchi T, Kawano A, Hosaka M, Hou N, Torii S. 2011 Luminal interaction of phogrin with carboxypeptidase E for effective targeting to secretory granules. Traffic 12:499-506
61. Machen TE, Leigh MJ, Taylor C, Kimura T, Asano S, Moore HP. 2003 pH of TGN and recycling endosomes of H+/K+-ATPase-transfected HEK-293 cells: implications for pH regulation in the secretory pathway. Am J Physiol Cell Physiol 285:C205-C214
62. De Matteis MA, Luini A. 2008 Exiting the Golgi complex. Nat Rev Mol Cell Biol 9:273-284
63. Hook VY, Mezey E, Fricker LD, Pruss RM, Siegel RE, Brownstein MJ. 1985 Immunochemical characterization of carboxypeptidase B-like peptide-hormone-processing enzyme. Proc Natl Acad Sci USA 82:4745-4749
64. Lynch DR, Braas KM, Hutton JC, Snyder SH. 1990 Carboxypeptidase E (CPE): immunocytochemical localization in the rat central nervous system and pituitary gland. J Neurosci 10:1592-1599
65. Lynch DR, Strittmatter SM, Snyder SH. 1984 Enkephalin convertase localization by [3H]guanidinoethylmercaptosuccinic acid autoradiography: selective association with enkephalin-containing neurons. Proc Natl Acad Sci USA 81:6543-6547
66. Strittmatter SM, Lynch DR, Snyder SH. 1984 [3H]guanidinoethylmercaptosuccinic acid binding to tissue homogenates. Selective labeling of enkephalin convertase. J Biol Chem 259:11812-11817
67. Strittmatter SM, Lynch DR, De Souza EB, Snyder SH. 1985 Enkephalin convertase demonstrated in the pituitary and adrenal gland by [3H]guanidinoethylmercaptosuccinic acid autoradiography: dehydration decreases neurohypophyseal levels. Endocrinology 117:1667-1674
68. Lynch DR, Strittmatter SM, Venable JC, Snyder SH. 1986 Enkephalin convertase: localization to specific neuronal pathways. J Neurosci 6:1662-1675
69. Strittmatter SM, Lynch DR, Snyder SH. 1986 Differential ontogeny of rat brain peptidases: prenatal expression of enkephalin convertase and postnatal development of angiotensin-converting enzyme. Brain Res 394:207-215
70. Lynch DR, Strittmatter SM, Venable JC, Snyder SH. 1987 Enkephalin convertase in the gastrointestinal tract and associated organs characterized and localized with [3H]guanidinoethylmercaptosuccinic acid. Endocrinology 121: 116-126
71. Lynch DR, Venable JC, Snyder SH. 1988 Enkephalin convertase in the heart: similar disposition to atrial natriuretic factor. Endocrinology 122:2683-2691
72. Lynch DR, Venable JC, Strittmatter SM, Snyder SH. 1988 Enkephalin convertase: characterization and localization using [3H]guanidinoethylmercaptosuccinic acid. Biochimie 70: 57-64
73. Hougaard DM, Larsson LI. 2004 Carboxypeptidase E in rat antropyloric mucosa: distribution in progenitor and mature endocrine cell types. Histochem Cell Biol 121: 55-61
74. Krajnik M, Schäfer M, Sobanski P, Kowalewski J, Bloch-Boguslawska E, Zylicz Z, Mousa SA. 2010 Enkephalin, its precursor, processing enzymes, and receptor as part of a local opioid network throughout the respiratory system of lung cancer patients. Hum Pathol 41:632-642
75. Mousa SA, Krajnik M, Sobanski P, Kowalewski J, Bloch-Boguslawska E, Zylicz Z, Schäfer M. 2010 Dynorphin expression, processing and receptors in the alveolar macro-phages, cancer cells and bronchial epithelium of lung cancer patients. Histol Histopathol 25:755-764
76. Fricker LD, Adelman JP, Douglass J, Thompson RC, von Strandmann RP, Hutton J. 1989 Isolation and sequence analysis of cDNA for rat carboxypeptidase E [EC 3.4.17.10], a neuropeptide processing enzyme. Mol Endocrinol 3:666-673
77. Zheng M, Streck RD, Scott RE, Seidah NG, Pintar JE. 1994 The developmental expression in rat of proteases furin, PC1, PC2, and carboxypeptidase E: implications for early maturation of proteolytic processing capacity. J Neurosci 14:4656-4673
78. Birch NP, Rodriguez C, Dixon JE, Mezey E. 1990 Distribution of carboxypeptidaseHmessengerRNAin rat brain using in situ hybridization histochemistry: implications for neuropeptide biosynthesis. Brain Res Mol Brain Res 7:53-59
79. MacCumber MW, Snyder SH, Ross CA. 1990 Carboxypeptidase E (enkephalin convertase): mRNA distribution in rat brain by in situ hybridization. J Neurosci 10:2850- 2860
80. SchäferMK,Day R, CullinanWE,ChrétienM,SeidahNG, Watson SJ. 1993 Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis. J Neurosci 13:1258-1279
81. Kershaw EE, Flier JS. 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
82. Ramis JM, Franssen-van HalNL,Kramer E, Llado I, Bouillaud F, Palou A, Keijer J. 2002 Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects. Cell Mol Life Sci 59:1960-1971
83. Greene D, Das B, Fricker LD. 1992 Regulation of carboxypeptidase E. Effect of pH, temperature and Co2+ on kinetic parameters of substrate hydrolysis. Biochem J 285: 613-618
84. Fricker LD. 2004 Carboxypeptidase E. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of proteolytic enzymes. 2nd ed. London: Academic Press; 840-844
85. Nalamachu SR, Song L, Fricker LD. 1994 Regulation of carboxypeptidase E. Effect of Ca2+ on enzyme activity and stability. J Biol Chem 269:11192-11195
86. Song L, Fricker LD. 1995 Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J Biol Chem 270:25007- 25013
87. Fricker LD, Plummer Jr TH, Snyder SH 1983 Enkephalin convertase: potent, selective, and irreversible inhibitors. Biochem Biophys Res Commun 111:994-1000
88. Bures EJ, Courchesne PL, Douglass J, Chen K, Davis MT, Jones MD, McGinley MD, Robinson JH, Spahr CS, Sun J, Wahl RC, Patterson SD. 2001 Identification of incompletely processed potential carboxypeptidase E substrates from CpEfat/CpEfat mice. Proteomics 1:79-92
89. Fricker LD. 2007 Neuropeptidomics to study peptide processing in animal models of obesity. Endocrinology 148: 4185-4190
90. Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA, Douglass J. 2000 Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 20:639-648
91. Gelman JS, Sironi J, Castro LM, Ferro ES, Fricker LD. 2010 Hemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation in Cpefat/fat mice. J Neurochem 113:871-880
92. Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, Heimann AS, Ferro ES, Scarlata S, Fricker LD, Devi LA. 2009 Novel endogenous peptide agonists of cannabinoid receptors. FASEB J 23:3020-3029
93. Che FY, Yan L, Li H, Mzhavia N, Devi LA, Fricker LD, 2001 Identification of peptides from brain and pituitary of Cpe(fat)/Cpe(fat) mice. Proc Natl Acad Sci USA 98:9971- 9976
94. Che FY, Biswas R, Fricker LD. 2005 Relative quantitation of peptides in wild-type and Cpe(fat/fat) mouse pituitary using stable isotopic tags and mass spectrometry. J Mass Spectrom 40:227-237
95. Che FY, Fricker LD. 2005 Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. J Mass Spectrom 40:238-249
96. Che FY, Yuan Q, Kalinina E, FrickerLD.2005 Peptidomics of Cpe fat/fat mouse hypothalamus: effect of food deprivation and exercise on peptide levels. J Biol Chem 280: 4451-4461
97. Décaillot FM, Che FY, Fricker LD, Devi LA. 2006 Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration. J Mol Neurosci 28:277-284
98. Che FY, Vathy I, Fricker LD. 2006 Quantitative peptidomics in mice: effect of cocaine treatment. J Mol Neurosci 28:265-275
99. Kelly RB 1985 Pathways of protein secretion in eukaryotes. Science 230:25-32
100. Wieland FT, Gleason ML, Serafini TA, Rothman JE. 1987 The rate of bulk flow from the endoplasmic reticulum to the cell surface. Cell 50:289-300
101. von Zastrow M, Link R, Daunt D, Barsh G, Kobilka B. 1993 Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J Biol Chem 268:763- 766
102. Kelly RB, Buckley KM, Burgess TL, Carlson SS, Caroni P, Hooper JE, Katzen A, Moore HP, Pfeffer SR, Schroer TA. 1983 Membrane traffic in neurons and peptide-secreting cells. Cold Spring Harb Symp Quant Biol 48:697-705
103. Green R, Shields D. 1984 Somatostatin discriminates between the intracellular pathways of secretory and membrane proteins. J Cell Biol 99:97-104
104. Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. 1977 Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science 197:1367-1369
105. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. 2000 Central nervous system control of food intake. Nature 404:661-671
106. Thoenen H. 2000 Neurotrophins and activity-dependent plasticity. Prog Brain Res 128:183-191
107. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR 2003 The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269
108. Arvan P, Kuliawat R, Prabakaran D, ZavackiAM,Elahi D, Wang S, Pilkey D. 1991 Protein discharge from immature secretory granules displays both regulated and constitutive characteristics. J Biol Chem 266:14171-14174
109. Kuliawat R, Arvan P. 1992 Protein targeting via the "constitutive-like" secretory pathway in isolated pancreatic islets: passive sorting in the immature granule compartment. J Cell Biol 118:521-529
110. Loh YP, Snell CR, Cool DR. 1997 Receptor-mediated targeting of hormones to secretory granules: role of carboxypeptidase E. Trends Endocrinol Metab 8:130-137
111. Van Horssen AM, Van Kuppeveld FJ, Martens GJ. 1998 Manipulation of disulfide bonds differentially affects the intracellular transport, sorting, and processing of neuroendocrine secretory proteins. J Neurochem 71:402-409
112. Mulcahy LR, Barker AJ, Nillni EA 2006 Disruption of disulfide bond formation alters the trafficking of prothyrotropin releasing hormone (proTRH)-derived peptides. Regul Pept 133:123-133
113. Gerdes HH, Rosa P, Phillips E, Baeuerle PA, Frank R, Argos P, Huttner WB, 1989 The primary structure of human secretogranin II, a widespread tyrosine-sulfated secretory granule protein that exhibits low pH- and calciuminduced aggregation. J Biol Chem 264:12009-12015
114. Chanat E, HuttnerWB. 1991 Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network. J Cell Biol 115:1505-1519
115. Bauerfeind R, HuttnerWB. 1993 Biogenesis of constitutive secretory vesicles, secretory granules and synaptic vesicles. Curr Opin Cell Biol 5:628-635
116. Canaff L, Brechler V, Reudelhuber TL, Thibault G. 1996 Secretory granule targeting of atrial natriuretic peptide correlates with its calcium-mediated aggregation. Proc Natl Acad Sci USA 93:9483-9487
117. Dikeakos JD, Reudelhuber TL. 2007 Sending proteins to dense core secretory granules: still a lot to sort out. J Cell Biol 177:191-196
118. Normant E, Loh YP. 1998 Depletion of carboxypeptidase E, a regulated secretory pathway sorting receptor, causes misrouting and constitutive secretion of proinsulin and proenkephalin, but not chromogranin A. Endocrinology 139:2137-2145
119. Loh YP, Maldonado A, Zhang C, Tam WH, Cawley N. 2002 Mechanism of sorting proopiomelanocortin and proenkephalin to the regulated secretory pathway of neuroendocrine cells. Ann NY Acad Sci 971:416-425
120. Lou H, Kim SK, Zaitsev E, Snell CR, Lu B, Loh YP. 2005 Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase E. Neuron 45:245-255
121. Dhanvantari S, Shen FS, Adams T, Snell CR, Zhang C, Mackin RB, Morris SJ, Loh YP. 2003 Disruption of a receptor-mediated mechanism for intracellular sorting of proinsulin in familial hyperproinsulinemia. Mol Endocrinol 17:1856-1867
122. Irminger JC, Verchere CB, Meyer K, Halban PA. 1997 Proinsulin targeting to the regulated pathway is not impaired in carboxypeptidase E-deficient Cpefat/Cpefat mice. J Biol Chem 272:27532-27534
123. Cawley NX, Rodriguez YM, Maldonado A, Loh YP. 2003 Trafficking of mutant carboxypeptidase E to secretory granules in a β-cell line derived from Cpe(fat)/Cpe(fat) mice. Endocrinology 144:292-298
124. Cawley NX, Yanik T, Woronowicz A, Chang W, Marini JC, Loh YP. 2010 Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density.AmJ Physiol Endocrinol Metab 299:E189-E197
125. Hosaka M, Watanabe T, Sakai Y, Kato T, Takeuchi T. 2005 Interaction between secretogranin III and carboxypeptidase E facilitates prohormone sorting within secretory granules. J Cell Sci 118:4785-4795
126. Kemppainen RJ, Behrend EN. 2010 Acute inhibition of carboxypeptidase E expression in AtT-20 cells does not affect regulated secretion of ACTH. Regul Pept 165:174- 179
127. Hall DH, Hedgecock EM. 1991 Kinesin-related gene unc-104 is required for axonal transport of synaptic vesicles in C. elegans. Cell 65:837-847
128. Otsuka AJ, Jeyaprakash A, García-Anoveros J, Tang LZ, Fisk G, Hartshorne T, Franco R, Born T. 1991 The C. elegans unc-104 gene encodes a putative kinesin heavy chain-like protein. Neuron 6:113-122
129. Hamm-Alvarez SF,DaCosta S, Yang T, Wei X, Gierow JP, Mircheff AK. 1997 Cholinergic stimulation of lacrimal acinar cells promotes redistribution of membrane-associated kinesin and the secretory protein, β-hexosaminidase, and increases kinesin motor activity. Exp Eye Res 64:141-156
130. Senda T, Yu W. 1999 Kinesin cross-bridges between neurosecretory granules and microtubules in the mouse neurohypophysis. Neurosci Lett 262:69-71
131. Varadi A, Tsuboi T, Johnson-Cadwell LI, Allan VJ, Rutter GA. 2003 Kinesin I and cytoplasmic dynein orchestrate glucose-stimulated insulin-containing vesicle movements in clonal MIN6 β-cells. Biochem Biophys Res Commun 311:272-282
132. Park JJ, Cawley NX, Loh YP. 2008 A bi-directional carboxypeptidase E-driven transport mechanism controls BDNF vesicle homeostasis in hippocampal neurons. Mol Cell Neurosci 39:63-73
133. Park JJ, Cawley NX, Loh YP. 2008 Carboxypeptidase E cytoplasmic tail-driven vesicle transport is key for activitydependent secretion of peptide hormones. Mol Endocrinol 22:989-1005
134. Rosé SD, Lejen T, Casaletti L, Larson RE, Pene TD, Trifaró JM. 2003 Myosins II andVin chromaffin cells: myosin V is a chromaffin vesicle molecular motor involved in secretion. J Neurochem 85:287-298
135. Rudolf R, Kögel T, Kuznetsov SA, Salm T, Schlicker O, Hellwig A, Hammer 3rd JA, Gerdes HH. 2003 Myosin Va facilitates the distribution of secretory granules in the Factin rich cortex of PC12 cells. J Cell Sci 116:1339-1348
136. Eichler TW, Kögel T, Bukoreshtliev NV, Gerdes H H. 2006 The role of myosin Va in secretory granule trafficking and exocytosis. Biochem Soc Trans 34:671-674
137. Shakiryanova D, Tully A, Levitan E.S. 2006 Activity-dependent synaptic capture of transiting peptidergic vesicles. Nat Neurosci 9:896-900
138. Goldstein LS, Yang Z. 2000 Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu Rev Neurosci 23:39-71
139. Zhang H, Li S, Wang M, Vukusic B, Pristupa ZB, Liu F. 2009 Regulation of dopamine transporter activity by carboxypeptidase E. Mol Brain 2:10
140. Oiso S, Takeda Y, Futagawa T, Miura T, Kuchiiwa S, Nishida K, Ikeda R, Kariyazono H, Watanabe K, Yamada K. 2009 Contactin-associated protein (Caspr) 2 interacts with carboxypeptidase E in the CNS. J Neurochem 109: 158-167
141. Zhu X, Wu K, Rife L, Cawley NX, Brown B, Adams T, Teofilo K, Lillo C, Williams DS, Loh YP, Craft CM. 2005 Carboxypeptidase E is required for normal synaptic transmission from photoreceptors to the inner retina. J Neurochem 95:1351-1362
142. Lou H, Park JJ, Cawley NX, Sarcon A, Sun L, Adams T, Loh YP. 2010 Carboxypeptidase E cytoplasmic tail mediates localization of synaptic vesicles to the pre-active zone in hypothalamic pre-synaptic terminals. J Neurochem 114: 886-896
143. BerezukMA,Schroer T.A. 2007 Dynactin enhances the processivity of kinesin-2. Traffic 8:124-129
144. Park JJ, Loh YP. 2008 How peptide hormone vesicles are transported to the secretion site for exocytosis. Mol Endocrinol 22:2583-2595
145. Klyachko VA, Jackson MB. 2002 Capacitance steps and fusion pores of small and large-dense-core vesicles in nerve terminals. Nature 418:89-92
146. Zhang Z, Bhalla A, Dean C, Chapman ER, Jackson MB. 2009 Synaptotagmin IV: a multifunctional regulator of peptidergic nerve terminals. Nat Neurosci 12:163-171
147. Weihe E, Tao-Cheng JH, Schäfer MK, Erickson JD, Eiden LE. 1996 Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc Natl Acad Sci USA 93:3547-3552
148. Liu Y, Edwards RH. 1997 Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells. J Cell Biol 139:907-916
149. Krantz DE, Waites C, Oorschot V, Liu Y, Wilson RI, Tan PK, Klumperman J, Edwards R.H. 2000 A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles. J Cell Biol 149:379-396
150. YaoJ, Erickson JD, Hersh L.B. 2004 Protein kinaseAaffects trafficking of the vesicular monoamine transporters in PC12 cells. Traffic 5:1006-1016
151. Rizzoli SO, Betz WJ. 2005 Synaptic vesicle pools. Nat Rev Neurosci 6:57-69
152. Ludwig M, Leng G. 2006 Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 7:126- 136
153. Hou JC, Min L, Pessin JE. 2009 Insulin granule biogenesis, trafficking and exocytosis. Vitam Horm 80:473-506
154. Liu Y, Schirra C, Edelmann L, Matti U, Rhee J, Hof D, Bruns D, Brose N, Rieger H, Stevens DR, Rettig J. 2010 Two distinct secretory vesicle-priming steps in adrenal chromaffin cells. J Cell Biol 190:1067-1077
155. Eiden LE. 1998 The cholinergic gene locus. J Neurochem 70:2227-2240
156. Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD. 2003 Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 23:9697- 9709
157. Cai Q, Lu L, Tian JH, Zhu YB, Qiao H, Sheng ZH. 2010 Snapin-regulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons. Neuron 68:73-86
158. Lorenzen A, Samosh J, Vandewark K, Anborgh PH, Seah C, Magalhaes AC, Cregan SP, Ferguson SS, Pasternak SH. 2010 Rapid and direct transport of cell surface APP to the lysosome defines a novel selective pathway.MolBrain 3:11
159. Coleman DL, Eicher EM. 1990 Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. J Hered 81:424-427
160. Berman Y, Mzhavia N, Polonskaia A, Devi LA. 2001 Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice. J Biol Chem 276:1466-1473
161. Varlamov O, Leiter EH, Fricker L. 1996 Induced and spontaneous mutations at Ser202 of carboxypeptidase E. Effect on enzyme expression, activity, and intracellular routing. J Biol Chem 271:13981-13986
162. Varlamov O, Fricker LD, Furukawa H, Steiner DF, Langley SH, Leiter EH. 1997 β-Cell lines derived from transgenic Cpe(fat)/Cpe(fat) mice are defective in carboxypeptidase E and proinsulin processing. Endocrinology 138: 4883-4892
163. Leiter EH, Kintner J, Flurkey K, Beamer WG, Naggert JK. 1999 Physiologic and endocrinologic characterization of male sex-biased diabetes in C57BLKS/J mice congenic for the fat mutation at the carboxypeptidease E locus. Endocrine 10:57-66
164. Prager R, Schernthaner G. 1982 Receptor binding properties of human insulin (recombinant DNA) and human proinsulin and their interaction at the receptor site. Diabetes Care 5(Suppl 2):104-106
165. Michael DJ, Geng X, Cawley NX, Loh YP, Rhodes CJ, Drain P, Chow. RH 2004 Fluorescent cargo proteins in pancreatic β-cells: design determines secretion kinetics at exocytosis. Biophys J 87:L03-L05
166. Yuan Q, Fontenele-Neto JD, Fricker LD. 2004 Effect of voluntary exercise on genetically obese Cpefat/fat mice: quantitative proteomics of serum. Obes Res 12:1179- 1188
167. Myers MG, Cowley MA, Münzberg H. 2008 Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537-556
168. Moran TH, Ameglio PJ, Schwartz GJ, McHugh PR. 1992 Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 262:R46-R50
169. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72
170. Cammisotto PG, Bukowiecki LJ. 2002 Mechanisms of leptin secretion from white adipocytes. Am J Physiol Cell Physiol 283:C244-C250
171. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. 1998 Un-raveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1:445-450
172. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S. 1998 Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393: 72-76
173. Wardlaw SL. 2011 Hypothalamic proopiomelanocortin processing and the regulation of energy balance. Eur J Pharmacol 660:213-219
174. Plum L, Lin HV, Dutia R, Tanaka J, Aizawa KS, Matsumoto M, Kim AJ, Cawley NX, Paik JH, Loh YP, DePinho RA, Wardlaw SL, Accili D. 2009 The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nat Med 15:1195-1201
175. del Giudice EM, Santoro N, Cirillo G, D'Urso L, Di Toro R, Perrone L. 2001 Mutational screening of theCARTgene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes 50:2157-2160
176. Yanik T, Dominguez G, Kuhar MJ, Del GiudiceEM,LohYP. 2006 The Leu34Phe ProCART mutation leads to cocaineand amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans. Endocrinology 147: 39-43
177. Asnicar MA, Smith DP, Yang DD, Heiman ML, Fox N, Chen YF, Hsiung HM, Köster A. 2001 Absence of cocaineand amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142:4394- 4400
178. Wierup N, Richards WG, Bannon AW, Kuhar MJ, Ahrén B, Sundler F. 2005 CART knock out mice have impaired insulin secretion and glucose intolerance, altered βcell morphology and increased body weight. Regul Pept 129: 203-211
179. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. 1986 Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:1189-1192
180. Baldock PA, Lee NJ, Driessler F, Lin S, Allison S, Stehrer B, Lin EJ, Zhang L, Enriquez RF, Wong IP, McDonald MM, During M, Pierroz DD, Slack K, Shi YC, Yulyaningsih E, Aljanova A, Little DG, Ferrari SL, Sainsbury A, Eisman JA, Herzog H. 2009 Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One 4:e8415
181. Lacourse KA, Friis-Hansen L, Samuelson LC, Rehfeld JF. 1998 Altered processing of procholecystokinin in carboxypeptidase E-deficient fat mice: differential synthesis in neurons and endocrine cells. FEBS Lett 436:61-66
182. Wang W, Cain BM, Beinfeld MC. 1998 Adult carboxypeptidase E-deficient fat/fat mice have a near-total depletion of brain CCK 8 accompanied by a massive accumulation of glycine and arginine extendedCCK:identification of CCK 8 Gly as the immediate precursor of CCK 8 in rodent brain. Endocrine 9:329-332
183. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K. 1997 Analysis of an expression profile of genes in the human adipose tissue. Gene 190:227-235
184. Lawler J. 2000 The functions of thrombospondin-1 and-2. Curr Opin Cell Biol 12:634-640
185. Chen H, Herndon ME, Lawler J. 2000 The cell biology of thrombospondin-1. Matrix Biol 19:597-614
186. Cammisotto PG, Bukowiecki LJ, Deshaies Y, Bendayan M. 2006 Leptin biosynthetic pathway in white adipocytes. Biochem Cell Biol 84:207-214
187. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317
188. Elefteriou F. 2008 Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 473:231-236
189. Ferron M, Hinoi E, Karsenty G, Ducy P. 2008 Osteocalcin differentially regulates cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266-5270
190. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H. 2002 Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109: 915-921
191. Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G. 2006 Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 147:3196-3202
192. Zhang M, Pritchard MR, Middleton FA, Horton JA, Damron TA. 2008 Microarray analysis of perichondral and reserve growth plate zones identifies differential gene expressions and signal pathways. Bone 43:511-520
193. Bray G.A.,York D.A. 1971 Genetically transmitted obesity in rodents. Physiol Rev 51:598-646
194. Srinivasan S, Bunch DO, Feng Y, Rodriguiz RM, Li M, Ravenell RL, Luo GX, Arimura A, Fricker LD, Eddy EM, Wetsel WC. 2004 Deficits in reproduction and pro-gonadotropin-releasing hormone processing in male Cpefat mice. Endocrinology 145:2023-2034
195. Wetsel WC, Mellon PL, Weiner RI, Negro-Vilar A. 1991 Metabolism of pro-luteinizing hormone-releasing hormone in immortalized hypothalamic neurons. Endocrinology 129:1584-1595
196. Wetsel WC, Liposits Z, Seidah NG, Collins S. 1995 Expression of candidate pro-GnRH processing enzymes in rat hypothalamus and an immortalized hypothalamic neuronal cell line. Neuroendocrinology 62:166-177
197. Beamer WG, Wilson MC, Leiter EH. 1983 Endocrinology. In: Foster HL, Small JD, Fox JG, eds. The mouse in biomedical research. Vol III. Normative biology, immunology, and husbandry.NewYork: Academic Press; 166-245
198. Vandenbergh JG. 1994 Pheromones and mammalian reproduction. In: Knobil E, Neill J, eds. The physiology of reproduction. New York: Raven Press; 343-359
199. Woronowicz A, Koshimizu H, Chang SY, CawleyNX,Hill JM, Rodriguiz RM, Abebe D, Dorfman C, Senatorov V, Zhou A, Xiong ZG, Wetsel WC, Loh YP. 2008 Absence of carboxypeptidase E leads to adult hippocampal neuronal degeneration and memory deficits. Hippocampus 18: 1051-1063
200. Koshimizu H, Senatorov V, Loh YP, Gozes I. 2009 Neuroprotective protein and carboxypeptidase E. J Mol Neurosci 39:1-8
201. NickellsRW,Schlamp CL, Newton AC, Williams D.S. 1993 Gene expression of the neuropeptide-processing enzyme carboxypeptidase E in rat photoreceptor cells. J Neurochem 61:1891-1900
202. Schlamp CL, Nickells RW. 1996 Light and dark cause a shift in the spatial expression of a neuropeptide-processing enzyme in the rat retina. J Neurosci 16:2164-2171
203. Coca-Prados M, Escribano J, Ortego J. 1999 Differential gene expression in the human ciliary epithelium. Prog Retin Eye Res 18:403-429
204. Ida H, Boylan SA, Weigel AL, Hjelmeland LM. 2003 Agerelated changes in the transcriptional profile of mouse RPE/choroid. Physiol Genomics 15:258-262
205. Schaefer AT, Larkum ME, Sakmann B, Roth A. 2003 Coincidence detection in pyramidal neurons is tuned by their dendritic branching pattern. J Neurophysiol 89:3143- 3154
206. JanYN,Jan LY. 2003 The control of dendrite development. Neuron 40:229-242
207. Singh KK, Park KJ, Hong EJ, Kramer BM, Greenberg ME, Kaplan DR, Miller FD. 2008 Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat Neurosci 11:649-658
208. Woronowicz A, Cawley NX, Chang SY, Koshimizu H, Phillips AW, Xiong ZG, Loh YP. 2010 Carboxypeptidase E knockout mice exhibit abnormal dendritic arborization and spine morphology in central nervous system neurons. J Neurosci Res 88:64-72
209. Pokorný J, Trojan S. 1983 Chronic changes in the receptive field of the pyramidal cells of the rat hippocampus after intermittent postnatal hypoxia. Physiol Bohemoslov 32: 393-402
210. Pokorný J, Trojan S. 1986 The development of hippocampal structure and how it is influenced by hypoxia. Acta Univ Carol Med Monogr 113:1-79
211. Groc L, Petanjek Z, Gustafsson B, Ben-Ari Y, Hanse E, Khazipov R. 2002 In vivo blockade of neural activity alters dendritic development of neonatal CA1 pyramidal cells. Eur J Neurosci 16:1931-1938
212. Silva-Gómez AB, Rojas D, Juárez I, Flores G. 2003 Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats. Brain Res 983:128-136
213. Parrish JZ, Emoto K, Kim MD, Jan Y.N. 2007 Mechanisms that regulate establishment, maintenance, and remodeling of dendritic fields. Annu Rev Neurosci 30:399-423
214. Cobos I, Calcagnotto ME, Vilaythong AJ, Thwin MT, Noebels JL, Baraban SC, Rubenstein JL. 2005 Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci 8:1059-1068
215. HandR, Bortone D, Mattar P,NguyenL,HengJI, Guerrier S, Boutt E, Peters E, Barnes AP, Parras C, Schuurmans C, Guillemot F, Polleux F. 2005 Phosphorylation of neurogenin 2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortex. Neuron 48:45-62
216. Cobos I, Borello U, Rubenstein JL. 2007 Dlx transcription factors promote migration through repression of axon and dendrite growth. Neuron 54:873-888
217. Lee KF, Bachman K, Landis S, Jaenisch R. 1994 Dependence on p75 for innervation of some sympathetic targets. Science 263:1447-1449
218. Kohn J, Aloyz RS, Toma JG, Haak-Frendscho M, Miller FD. 1999 Functionally antagonistic interactions between the TrkA and p75 neurotrophin receptors regulate sympathetic neuron growth and target innervation. J Neurosci 19:5393-5408
219. Singh KK, Miller FD. 2005 Activity regulates positive and negative neurotrophin-derived signals to determine axon competition. Neuron 45:837-845
220. Jaworski J, Sheng M. 2006 The growing role of mTOR in neuronal development and plasticity. Mol Neurobiol 34: 205-219
221. Johnson EM, Craig ET, Yeh HH. 2007 TrkB is necessary for pruning at the climbing fibre-Purkinje cell synapse in the developing murine cerebellum. J Physiol 582:629-646
222. Brzustowicz LM, Simone J, Mohseni P, Hayter JE, Hodgkinson KA, Chow EW, Bassett AS. 2004 Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am J Hum Genet 74:1057-1063
223. Xu B, Wratten N, Charych EI, Buyske S, Firestein BL, Brzustowicz L.M. 2005 Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Med 2:e263
224. Zheng Y, Li H, Qin W, Chen W, Duan Y, Xiao Y, Li C, Zhang J, Li X, Feng G, He L. 2005 Association of the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population. Biochem Biophys Res Commun 328:809-815
225. Kremeyer B, García J,Kymäläinen H, Wratten N, Restrepo G, Palacio C, Miranda AL, López C, Restrepo M, Bedoya G, Brzustowicz LM, Ospina-Duque J, Arbeláez MP, Ruiz-Linares A. 2009 Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate. Hum Hered 67:163-173
226. Wratten NS, Memoli H, Huang Y, Dulencin AM, Matteson PG, Cornacchia MA, Azaro MA, Messenger J, Hayter JE, Bassett AS, Buyske S, Millonig JH, Vieland VJ, Brzustowicz LM. 2009 Identification of a schizophrenia-associated functional noncoding variant in NOS1AP. Am J Psychiatry 166:434-441
227. Carrel D, Du Y, Komlos D, Hadzimichalis NM, Kwon M, Wang B, Brzustowicz LM, Firestein BL. 2009 NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway. J Neurosci 29:8248-8258
228. Matsuzaki M. 2007 Factors critical for the plasticity of dendritic spines and memory storage. Neurosci Res 57:1-9
229. Bourne JN, Harris K.M. 2008 Balancing structure and function at hippocampal dendritic spines. Annu Rev Neurosci 31:47-67
230. De Roo M, Klauser P, Garcia PM, Poglia L, Muller D. 2008 Spine dynamics and synapse remodeling during LTP and memory processes. Prog Brain Res 169:199-207
231. Jin K, Graham SH, Nagayama T, Goldsmith PC, Greenberg DA, Zhou A, Simon RP. 2001 Altered expression of the neuropeptide-processing enzyme carboxypeptidase E in the rat brain after global ischemia. J Cereb Blood Flow Metab 21:1422-1429
232. Jeffrey KD, Alejandro EU, Luciani DS, Kalynyak TB, Hu X, Li H, Lin Y, Townsend RR, Polonsky KS, Johnson JD. 2008 Carboxypeptidase E mediates palmitate-induced cell ER stress and apoptosis. Proc Natl Acad Sci USA 105:8452-8457
233. Johnson JD. 2009 Proteomic identification of carboxypeptidase E connects lipid-induced βcell apoptosis and dysfunction in type 2 diabetes. Cell Cycle 8:38-42
234. Dobkin RD, Leiblum SR, Rosen RC, Menza M, Marin H. 2006 Depression and sexual functioning in minority women: current status and future directions. J Sex Marital Ther 32:23-36
235. fat/fat mice. Fortyseventh Annual Meeting of the American College of Neuropsychopharmacology, Scottsdale, AZ, 2008, (Poster 81)
236. Tollefson GD, Rosenbaum JF. 1998 Selective serotonin reuptake inhibitors. In: Schatzberg AF, Nemeroff CB, ed. Textbook of psychopharmacology. 2nd ed. Washington, DC: American Psychiatric Press, Inc.; 219-237
237. Zimmerman M, Chelminski I, McDermut W. 2002 Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 63:187-193
238. Morris RG, Schenk F, Tweedie F, Jarrard LE. 1990 Ibotenate lesions of hippocampus and/or subiculum: dissociating components of allocentric spatial learning. Eur J Neurosci 2:1016-1028
239. Kogan JH, Frankland PW, Silva AJ. 2000 Long-term memory underlying hippocampus-dependent social recognition in mice. Hippocampus 10:47-56
240. Dere E, Huston JP, De Souza Silva MA. 2007 The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 31: 673-704
241. Murthy SR, Pacak K, Loh YP. 2010 Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers. Cell Mol Neurobiol 30:1377-1381
242. Weber RG, Rieger J, Naumann U, Lichter P, Weller M. 2001 Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines. Int J Cancer 91:213-218
243. Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, Flotte TJ, Duncan LM, Granter SR, Chin L. 2006 Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125:1269-1281
244. Azzoni C, D'Adda T, Tamburrano G, Coscelli C, Madsen OD, Scopsi L, Bordi C. 1998 Functioning human insulinomas. An immunohistochemical analysis of intracellular insulin processing. Virchows Arch 433:495-504
245. Höcker M, John M, Anagnostopoulos J, Buhr HJ, Solimena M, Gasnier B, Henry JP, Wang TC, Wiedenmann B. 1999 Molecular dissection of regulated secretory pathways in human gastric enterochromaffin-like cells: an immunohistochemical analysis. Histochem Cell Biol 112: 205-214
246. Fan X, Olson SJ, Blevins LS, Allen GS, Johnson M.D. 2002 Immunohistochemical localization of carboxypeptidases D, E, and Z in pituitary adenomas and normal human pituitary. J Histochem Cytochem 50:1509-1516
247. North WG, Du J. 1998 Key peptide processing enzymes are expressed by a variant form of small-cell carcinoma of the lung. Peptides 19:1743-1747
248. He P, Varticovski L, Bowman ED, Fukuoka J, Welsh JA, Miura K, Jen J, Gabrielson E, Brambilla E, Travis WD, Harris CC. 2004 Identification of carboxypeptidase E and -glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol 35:1196-1209
249. Rozengurt E. 2002 Neuropeptides as growth factors for normal and cancerous cells. Trends Endocrinol Metab 13: 128-134
250. Morris DG, Musat M, Czirják S, Hanzély Z, Lillington DM, Korbonits M, Grossman AB. 2005 Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 153:143-151
251. Tatsumi KI, Tanaka S, Takano T, Tahara S, Murakami Y, Takao T, Hashimoto K, Kato Y, Teramoto A, Amino N. 2003 Frequent appearance of autoantibodies against prohormone convertase 1/3 and neuroendocrine protein 7B2 in patients with nonfunctioning pituitary macroadenoma. Endocrine 22:335-340
252. DeLellis RA, Lloyd RV, Heitz PU, Eng C. 2004 Tumours of endocrine organs. Lyon, France: IARC Press
253. Manger WM, Eisenhofer G. 2004 Pheochromocytoma: diagnosis and management update. Curr Hypertens Rep 6:477-484
254. Pacak K, Lenders JWM, Eisenhofer G. 2007 Pheochromocytoma: diagnosis, localization and treatment. Malden, MA: Blackwell Publishing
255. Eisenhofer G, Pecorella W, Pacak K, Hooper D, Kopin IJ, Goldstein DS. 1994 The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats. J Auton Nerv Syst 50:93-107
256. Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders JW. 1998 Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 83:2175- 2185
257. van Duinen N, Steenvoorden D, Kema IP, Jansen JC, Vriends AH, Bayley JP, Smit JW, Romijn JA, Corssmit EP. 2010 Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. J Clin Endocrinol Metab 95:209-214
258. Eisenhofer G, Lenders JW, Timmers H, MannelliM,Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K. 2011 Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 57:411-420
259. Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR. 1999 Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340:1872-1879
260. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. 2002 Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287:1427-1434
261. Sawka AM, Jaeschke R, Singh RJ, Young Jr WF. 2003 A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88: 553-558
262. Sawka AM, Gafni A, Thabane L, Young Jr WF. 2004 The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab 89:2859-2866
263. Unger N, Pitt C, Schmidt IL, Walz MK, Schmid KW, Philipp T, Mann K, Petersenn S. 2006 Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 154:409-417
264. Grouzmann E, Drouard-Troalen L, Baudin E, Plouin PF, Muller B, Grand D, Buclin T. 2010 Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur J Endocrinol 162:951-960
265. Sutton MG, Sheps SG, Lie JT. 1981 Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56:354-360
266. McNeil AR, Blok BH, Koelmeyer TD, Burke MP, Hilton JM. 2000 Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. AustN Z J Med 30:648-652
267. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP, Plouin PF. 2007 Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92:3822-3828
268. Young Jr WF. 2007 Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356:601-610
269. Cascón A, Pita G, Burnichon N, Landa I, López-Jiménez E, Montero-Conde C, Leskelä S, Leandro-García LJ, Letón R, Rodríguez-Antona C, Díaz JA, López-Vidriero E, González-Neira A, Velasco A, Matias-Guiu X, Gimenez-Roqueplo AP, Robledo M. 2009 Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab 94:1701-1705
270. O'Riordain DS, Young Jr WF, Grant CS, Carney JA, van Heerden JA. 1996 Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg 20:916- 921; discussion 922
271. Mannelli M, Ianni L, Cilotti A, Conti A. 1999 Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol 141:619-624
272. Park J, Song C, Park M, Yoo S, Park SJ, Hong S, Hong B, Kim CS, Ahn H. 2011 Predictive characteristics of malignant pheochromocytoma. Korean J Urol 52:241-246
273. Zelinka T, Musil Z, Dušková J, Burton D, Merino MJ, Milosevic D, Widimský Jr J, Pacak K. 2011 Metastatic pheochromocytoma: does the size and age matter? Eur J Clin Invest 41:1121-1128
274. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, ApelTW,Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C, Eng C. 2002 Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459-1466
275. BennDE,Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG. 2006 Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 91:827-836
276. Plouin PF, Gimenez-Roqueplo AP. 2006 The genetic basis of pheochromocytoma: who to screen and how? Nat Clin Pract Endocrinol Metab 2:60-61
277. Petri BJ, van Eijck CH, de Herder WW, Wagner A, de Krijger RR. 2009 Phaeochromocytomas and sympathetic paragangliomas. Br J Surg 96:1381-1392
278. Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA, Suárez C, Hussain AK, Vriends AH, Hes FJ, Jansen JC, Tops CM, Corssmit EP, de Knijff P, Lenders JW, Cremers CW, Devilee P, Dinjens WN, de Krijger RR, Robledo M. 2010 SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 11:366-372
279. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. 2005 Phaeochromocytoma. Lancet 366:665-675
280. Müller U, Troidl C, Niemann S. 2005 SDHC mutations in hereditary paraganglioma/pheochromocytoma. Fam Cancer 4:9-12
281. Schiavi F, Savvoukidis T, Trabalzini F, Grego F, Piazza M, Amista' P, Dematte' S, Del Piano A, Cecchini ME, Erlic Z, De Lazzari P, Mantero F, Opocher G. 2006 Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas. Ann NY Acad Sci 1073:190- 197
282. Burnichon N, Brie're JJ, Libé R, Vescovo L, Rivie're J, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP. 2010 SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19:3011-3020
283. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SP, Stiles C, Aguiar RC, Dahia PL. 2010 Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 42:229-233
284. Yao L, Schiavi F, Cascon A, Qin Y, Inglada-Pérez L, King EE, Toledo RA, Ercolino T, Rapizzi E, Ricketts CJ, Mori L, Giacche' M, Mendola A, Taschin E, Boaretto F, Loli P, Iacobone M, Rossi GP, Biondi B, Lima-Junior JV, Kater CE, Bex M, Vikkula M, Grossman AB, Gruber SB, Barontini M, Persu A, Castellano M, Toledo SP, Maher ER, MannelliM,Opocher G, RobledoM,Dahia PL. 2010 Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 304: 2611-2619
285. Neumann HP, Sullivan M, Winter A, Malinoc A, HoffmannMM, Boedeker CC, Bertz H, WalzMK,Moeller LC, Schmid KW, Eng C. 2011 Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. J Clin Endocrinol Metab 96:E1279-E1282
286. Krawczak M, Reiss J, Cooper DN. 1992 The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54
287. Martin N, Boomsma D, Machin G. 1997 A twin-pronged attack on complex traits. Nat Genet 17:387-392
288. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A. 1999 Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247
289. Lohrer HD, Tangen U. 2000 Investigations into the molecular effects of single nucleotide polymorphism. Pathobiology 68:283-290
290. LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, Vercelli D. 2001Acommon single nucleotide polymorphism in theCD14promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167:5838-5844
291. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, Evans CM, Garantziotis S, Adler KB, Dickey BF, du Bois RM, Yang IV, Herron A, Kervitsky D, Talbert JL, Markin C, Park J, Crews AL, Slifer SH, Auerbach S, Roy MG, Lin J, Hennessy CE, Schwarz MI, Schwartz DA. 2011 A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364:1503-1512
292. Sonuga-Barke EJ, Kumsta R, Schlotz W, Lasky-Su J, Marco R, Miranda A, Mulas F, Oades RD, Banaschewski T, Mueller U, Andreou P, Christiansen H, Gabriels I, Uebel H, Kuntsi J, Franke B, Buitelaar J, Ebstein R, GillM,Anney R, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Asherson P, Faraone SV. 2011 A functional variant of the serotonin transporter gene (SLC6A4) moderates impulsive choice in attention deficit/hyperactivity disorder boys and siblings. Biol Psychiatry 70:230-236
293. Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A, Keilhauer CN, Weber BH. 2008 Age-related macular degeneration is associated with an unstableARMS2(LOC387715) mRNA. Nat Genet 40:892-896
294. Magyar I, Colman D, Arnold E, Baumgartner D, Bottani A, Fokstuen S, Addor MC, Berger W, Carrel T, Steinmann B,Mátyás G. 2009 Quantitative sequence analysis ofFBN1 premature termination codons provides evidence for incompleteNMDin leukocytes. Hum Mutat 30:1355-1364
295. Pointon JJ, Lok CY, Shearman JD, Suckling RJ, Rochette J, Merryweather-Clarke AT, Robson KJ. 2009 A novel HFE mutation (c.del478) results in nonsense-mediated decay of the mutant transcript in a hemochromatosis patient. Blood Cells Mol Dis 43:194-198
296. Shin JA, Chang HS, Park SM, Jang AS, Park SW, Park JS, Uh ST, Il Lim G, Rhim T, Kim MK, Choi IS, Chung IY, Park BL, Shin HD, Park CS. 2009 Genetic effect of Cys-LTR2 polymorphisms on its mRNA synthesis and stabilization. BMC Med Genet 10:106
297. Hoffmann M, Schirmer MA, Tzvetkov MV, Kreuz M, Ziepert M, Wojnowski L, Kube D, Pfreundschuh M, Trümper L, Loeffler M, Brockmöller J. 2010 A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma. Cancer Res 70:2328-2338
298. Garcia-Rostan G, Tallini G, Herrero A, D'AquilaTG,Carcangiu ML, Rimm DL. 1999 Frequent mutation and nuclear localization of catenin in anaplastic thyroid carcinoma. Cancer Res 59:1811-1815
299. Kammerer S, Burns-Hamuro LL, Ma Y, Hamon SC, Canaves JM, Shi MM, Nelson MR, Sing CF, Cantor CR, Taylor SS, Braun A. 2003 Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc Natl Acad Sci USA 100:4066-4071
300. Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D. 2004 A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 279:27233-27238
301. Leskelä TT, Markkanen PM, Alahuhta IA, Tuusa JT, Petä jä-Repo UE. 2009 Phe27Cys polymorphism alters the maturation and subcellular localization of the human opioid receptor. Traffic 10:116-129
302. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. 2008 Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 29:1306-1311
303. Saunders MA, Liang H, Li WH. 2007 Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104:3300-3305
304. Hall C, Manser E, Spurr NK, Lim L. 1993 Assignment of the human carboxypeptidase E (CPE) gene to chromosome Genomics 15:461-463
305. Utsunomiya N, Ohagi S, Sanke T, Tatsuta H, Hanabusa T, Nanjo K. 1998 Organization of the human carboxypeptidase E gene and molecular scanning for mutations in Jap-anese subjects with NIDDM or obesity. Diabetologia 41: 701-705
306. Chen H, Jawahar S, Qian Y, Duong Q, Chan G, Parker A, Meyer JM, Moore KJ, Chayen S, Gross DJ, Glaser B, Permutt MA, Fricker LD. 2001 Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activity. Hum Mutat 18:120-131
307. Jia EZ, Wang J, Yang ZJ, Zhu TB, Wang LS, Chen B, Cao KJ, Huang J, Ma WZ. 2008 Molecular scanning of the human carboxypeptidase E gene for mutations in Chinese subjects with coronary atherosclerosis. Mol Cell Biochem 307:31-39
308. Wang J, Zhang Y, Yang ZJ, Zhu TB, Wang LS, Chen B, Cao KJ, Huang J, Ma WZ, Jia EZ. 2008 Association of human carboxypeptidase E exon5 gene polymorphisms with angiographical characteristics of coronary atherosclerosis in a Chinese population. Acta Pharmacol Sin 29: 736-744
309. Jia EZ, Wang J, Yang ZJ, Zhu TB, Wang LS, Wang H, Li CJ, Chen B, Cao KJ, Huang J, Ma WZ. 2009 Association of the mutation for the human carboxypeptidase E gene exon 4 with the severity of coronary artery atherosclerosis. Mol Biol Rep 36:245-254
310. Gabbay KH, DeLuca K, Fisher Jr JN, Mako ME, Rubenstein AH. 1976 Familial hyperproinsulinemia. An autosomal dominant defect. N Engl J Med 294:911-915
311. Chan SJ, Seino S, Gruppuso PA, Schwartz R, Steiner DF. 1987 A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia. Proc Natl Acad Sci USA 84:2194- 2197
312. Carroll RJ, Hammer RE, Chan SJ, Swift HH, Rubenstein AH, Steiner DF. 1988 A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. Proc Natl Acad Sci USA 85: 8943-8947
313. Wang XC, Xu SY, Wu XY, Song HD, Mao YF, Fan HY, Yu F,MouB,GuYY,XuLQ, Zhou XO, Chen Z, Chen JL, Hu RM. 2004 Gene expression profiling in human insulinoma tissue: genes involved in the insulin secretion pathway and cloning of novel full-length cDNAs. Endocr Relat Cancer 11:295-303
314. Polastri L, Galbiati F, Folli F, Davalli AM. 2002 Effects of carboxypeptidase E overexpression on insulin mRNA levels, regulated insulin secretion, and proinsulin processing of pituitary GH3 cells transfected with a furin-cleavable human proinsulin cDNA. Cell Transplant 11:803-811
315. Zhou ZG, Yang L, Huang G. 2003 Diagnostic value of carboxypeptidase-H autoantibodies in detecting latent autoimmune diabetes in adults. Hunan Yi Ke Da Xue Xue Bao 28:549-552
316. Li LR, Zhou ZG, Huang G, Yang L, Li X, Chen XY, He L. 2005 [Diagnostic role of SOX13 antibody in latent autoimmune diabetes of adults]. Zhonghua Yi Xue Za Zhi 85: 235-239
317. Zhang D, Zhou Z, Li L, Weng J, Huang G, Jing P, Zhang C, Peng J, Xiu L. 2006 Islet autoimmunity and genetic mutations in Chinese subjects initially thought to have type 1B diabetes. Diabet Med 23:67-71
318. Yang L, Zhou ZG, Tan SZ, Huang G, Jin P, Yan X, Li X, Peng H, Hagopian W. 2008 Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults. Ann NY Acad Sci 1150:263-266
319. Ibrahim SM, Mix E, Böttcher T, Koczan D, Gold R, Rolfs A, Thiesen HJ. 2001 Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 124:1927-1938
320. Mazón Peláez I, Vogler S, Strauss U, Wernhoff P, Pahnke J, Brockmann G, Moch H, Thiesen HJ, Rolfs A, Ibrahim SM. 2005 Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease. Hum Mol Genet 14:1977- 1989
321. Stahl S, Reinders Y, Asan E, Mothes W, Conzelmann E, Sickmann A, Felbor U. 2007 Proteomic analysis of cathepsin B- and L-deficient mouse brain lysosomes. Biochim Biophys Acta 1774:1237-1246
322. Castresana J. 2000 Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol Biol Evol 17:540-552
323. Edgar RC. 2004 MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792-1797
324. Lee NK, Karsenty G. 2008 Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 19: 161-166
325. Evans JF, Niu QT, Canas JA, Shen CL, Aloia JF, Yeh JK. 2004 ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes. Bone 35:96-107
326. Zhong Q, Sridhar S, Ruan L, Ding KH, Xie D, Insogna K, Kang B, Xu J, Bollag RJ, Isales CM. 2005 Multiple melanocortin receptors are expressed in bone cells. Bone 36: 820-831
327. Fu Y, Luo N, Klein RL, Garvey WT. 2005 Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 46:1369-1379
328. Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ, Robert JJ, Vinson C, Nakao K, Capeau J, Karsenty G. 2004 Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 101:3258-3263
329. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G.2005 Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-520
330. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G,Guo J, Delaney J, Boyle WJ. 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
331. Bae S, Ha TS, Yoon Y, Lee J, Cha HJ, Yoo H, Choe TB, Li S, Sohn I, Kim JY, Kim CS, Jin HO, Lee HC, Park IC, Kim CS, Jin YW, Ahn SK. 2008 Genome-wide screening and identification of novel proteolytic cleavage targets of caspase-8 and -10 in vitro. Int J Mol Med 21:381-386
332. Bogan RL, Murphy MJ, Stouffer RL, Hennebold JD. 2008 Systematic determination of differential gene expression in the primate corpus luteum during the luteal phase of the menstrual cycle. Mol Endocrinol 22:1260-1273
333. Chikuma T, Inomata Y, Tsuchida K, Hojo H, Kato T. 2002 Effect of monensin on the levels of tachykinins and their processing enzyme activity in rat dorsal root ganglia. Neurosci Lett 326:89-92
334. Cook JL, Giardina JF, Zhang Z, Re RN. 2002 Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells. J Mol Cell Cardiol 34:1525-1537
335. Dong W, Fricker LD, Day R. 1999 Carboxypeptidase D is a potential candidate to carry out redundant processing functions of carboxypeptidaseEbased on comparative distribution studies in the rat central nervous system. Neuroscience 89:1301-1317
336. Du J, Keegan BP, North W.G. 2001 Key peptide processing enzymes are expressed by breast cancer cells. Cancer Lett 165:211-218
337. Grigoriants O, Devi L, Fricker LD. 1993 Dopamine antagonist haloperidol increases carboxypeptidase E mRNA in rat neurointermediate pituitary but not in various other rat tissues. Brain Res Mol Brain Res 19:161-164
338. Guyonnet B, Marot G, Dacheux JL, Mercat MJ, Schwob S, Jaffrézic F, Gatti JL. 2009 The adult boar testicular and epididymal transcriptomes. BMC Genomics 10:369
339. Haegeman A, Williams JL, Law A, Van Zeveren A, Peelman LJ. 2003 Mapping and SNP analysis of bovine candidate genes for meat and carcass quality. Anim Genet 34: 349-353
340. Ishizuka N, Minami K, Okumachi A, Okuno M, Seino S. 2007 Induction by NeuroD of the components required for regulated exocytosis. Biochem Biophys Res Commun 354: 271-277
341. Johnston RA, Theman TA, Shore SA. 2006 Augmented responses to ozone in obese carboxypeptidase E-deficient mice.AmJ Physiol Regul Integr Comp Physiol 290:R126- R133
342. Johnston RA, Zhu M, Hernandez CB, Williams ES, Shore SA. 2010 Onset of obesity in carboxypeptidase E-deficient mice and effect on airway responsiveness and pulmonary responses to ozone. J Appl Physiol 108:1812-1819
343. Maresh JG, Xu H, Jiang N, Gairola CG, Shohet RV. 2005 Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo. Physiol Genomics 21:308-313
344. Marquínez AC, Andreetta AM, González N, Wolfenstein-Todel C, Scacciati de Cerezo JM. 2003 Identification of gp17 glycoprotein and characterization of prostatic acid phosphatase (PAP) and carboxypeptidase E (CPE) fragments in a human seminal plasma fraction interacting with concanavalin A. J Protein Chem 22:423-429
345. Mousa SA, Shakibaei M, Sitte N, Schäfer M, Stein C. 2004 Subcellular pathways of -endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145:1331-1341
346. Mukhina ES, Saldaev DA, Vernigora AN, Gengin MT. 2005 [The effect of ethanol consumption by dams on the offspring locomotion in the open field test and carboxypeptidase activities in the rat brain and adrenal medulla]. Ross Fiziol Zh Im I M Sechenova 91:239-245
347. Nakajima E, David LL, Riviere MA, Azuma M, Shearer TR. 2009 Humanand monkey lenses cultured with calcium ionophore form B-crystallin lacking the C-terminal lysine, a prominent feature of some human cataracts. Invest Ophthalmol Vis Sci 50:5828-5836
348. Pilot-Storck F, Chopin E, Rual JF, Baudot A, Dobrokhotov P, Robinson-Rechavi M, Brun C, Cusick ME, Hill DE, Schaeffer L, Vidal M, Goillot E. 2010 Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor. Mol Cell Proteomics 9:1578-1593
349. Prasad SS, Cynader MS. 1994 Identification of cDNA clones expressed selectively during the critical period for visual cortex development by subtractive hybridization. Brain Res 639:73-84
350. Rawdon BB, Larsson LI. 2000 Development of hormonal peptides and processing enzymes in the embryonic avian pancreas with special reference to co-localisation. Histochem Cell Biol 114:105-112
351. Reznik SE, Salafia CM, Lage JM, Fricker LD. 1998 Immunohistochemical localization of carboxypeptidases E and D in the human placenta and umbilical cord. J Histochem Cytochem 46:1359-1368
352. Sasson R, Dantes A, Tajima K, Amsterdam A. 2003 Novel genes modulated byFSHin normal and immortalized FSHresponsive cells: new insights into the mechanism of FSH action. FASEB J 17:1256-1266
353. Sekiguchi T, Kawashima T, Satou Y, Satoh N. 2007 Further EST analysis of endocrine genes that are preferentially expressed in the neural complex of Ciona intestinalis: receptor and enzyme genes associated with endocrine system in the neural complex. Gen Comp Endocrinol 150:233- 245
354. Singh U, Yu Y, Kalinina E, Konno T, Sun T, Ohta H, Wakayama T, Soares MJ, Hemberger M, Fundele RH. 2006 Carboxypeptidase E in the mouse placenta. Differentiation 74:648-660
355. Tang SS, Zhang JH, Liu HX, Li HZ. 2009 PC2/CPE-mediated pro-protein processing in tumor cells and its differentiated cells or tissues. Mol Cell Endocrinol 303:43-49
356. Tang SS, Zhang JH, Liu HX, Zhou D, Qi R. 2009 Proprotein convertase-2/carboxypeptidase-E mediated neuropeptide processing of RGC-5 cell after in vitro ischemia. Neurosci Bull 25:7-14
357. Vilijn MH, Das B, Kessler JA, Fricker LD. 1989 Cultured astrocytes and neurons synthesize and secrete carboxypeptidase E, a neuropeptide-processing enzyme. J Neurochem 53:1487-1493
358. Wang X, Huynh H, Gjörloff-Wingren A, Monosov E, Stridsberg M, Fukuda M, Mustelin T. 2002 Enlargement of secretory vesicles by protein tyrosine phosphatase PTPMEG2 in rat basophilic leukemia mast cells and Jurkat T cells. J Immunol 168:4612-4619
359. Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan W M, Adams K, Timmers HJ, Pacak K. 2011 Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer Oct 28, 10.1016/j.ejca.2011.07.016